Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History MDGL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics MDGL

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Madrigal Pharmaceuticals Inc

MDGL
Current price
348.73 USD +5.73 USD (+1.67%)
Last closed 344.97 USD
ISIN US5588681057
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 7 659 472 384 USD
Yield for 12 month +24.93 %
1Y
3Y
5Y
10Y
15Y
MDGL
21.11.2021 - 28.11.2021

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania. Address: Four Tower Bridge, West Conshohocken, PA, United States, 19428

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

423.14 USD

P/E Ratio

Dividend Yield

Financials MDGL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures MDGL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+180 133 000 USD

Last Year

Current Quarter

+137 250 000 USD

Last Quarter

+103 320 000 USD

Current Year

+173 900 000 USD

Last Year

-527 000 USD

Current Quarter

+132 737 000 USD

Last Quarter

+100 310 000 USD
EBITDA -423 841 984 USD
Operating Margin TTM -57.79 %
Price to Earnings
Return On Assets TTM -25.56 %
PEG Ratio
Return On Equity TTM -50.16 %
Wall Street Target Price 423.14 USD
Revenue TTM 317 383 008 USD
Book Value 32.03 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 306 636 992 USD
Earnings per share -17.83 USD
Diluted Eps TTM -17.83 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -123.38 %

Stock Valuation MDGL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 21.85
Price Sales TTM 24.13
Enterprise Value EBITDA -8.32
Price Book MRQ 10.78

Technical Indicators MDGL

For 52 Weeks

200.63 USD 377.46 USD
50 Day MA 290.86 USD
Shares Short Prior Month 4 152 509
200 Day MA 300.00 USD
Short Ratio 13.32
Shares Short 3 966 696
Short Percent 21.68 %